| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2021-05-25 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 845 | $424.00 | $358,280.00 | -51.0% | → |
| 2021-02-12 | Hippel James | Chief Financial Officer | Sale+OE | 10,000 | $400.39 | $4,003,908.16 | -34.6% | → |
| 2021-02-12 | Furlow Brenda S. | SVP - General Counsel | Sale+OE | 10,000 | $398.64 | $3,986,352.38 | -39.1% | → |
| 2021-02-08 | Nusse Roeland | - | Sale+OE | 6,000 | $385.08 | $2,310,481.20 | -47.0% | → |
| 2021-02-05 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 823 | $388.45 | $319,694.35 | -49.3% | → |
| 2021-02-05 | Eansor Norman David | President-Protein Sciences | Sale+OE | 32,933 | $380.68 | $12,537,022.91 | -29.4% | → |
| 2021-01-15 | Kummeth Charles R. | Chief Executive Officer | Sell | 20,000 | $344.00 | $6,880,000.00 | -12.0% | → |
| 2021-01-11 | Hippel James | Chief Financial Officer | Sale+OE | 10,000 | $333.63 | $3,336,322.32 | -10.0% | → |
| 2020-12-07 | Kummeth Charles R. | Chief Executive Officer | Sell | 5,000 | $308.00 | $1,540,000.00 | -2.9% | → |
| 2020-11-30 | Furlow Brenda S. | SVP - General Counsel | Sale+OE | 10,857 | $301.94 | $3,278,126.24 | -29.0% | → |
| 2020-11-18 | BAUMGARTNER ROBERT V | - | Sale+OE | 5,000 | $303.34 | $1,516,675.00 | -34.2% | → |
| 2020-11-11 | Hippel James | Chief Financial Officer | Sale+OE | 10,991 | $307.95 | $3,384,680.03 | -13.3% | → |
| 2020-11-09 | Seth Alpna | - | Sale+OE | 5,023 | $306.62 | $1,540,166.67 | -38.7% | → |
| 2020-11-06 | STEER RANDOLPH C | - | Sale+OE | 10,000 | $301.99 | $3,019,947.92 | -15.1% | → |
| 2020-11-06 | HIGGINS JOHN L | - | Sale+OE | 5,000 | $300.35 | $1,501,744.14 | -20.1% | → |
| 2020-11-05 | Hippel James | Chief Financial Officer | Sale+OE | 4,351 | $283.44 | $1,233,255.83 | -4.5% | → |